TYVASO (United Therapeutics Corp.)
Welcome to the PulseAid listing for the TYVASO drug offered from United Therapeutics Corp.. This Prostacycline Vasodilator [EPC],Prostaglandins I [Chemical/Ingredient],Vasodilation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | United Therapeutics Corp. |
| NON-PROPRIETARY NAME: | treprostinil |
| SUBSTANCE NAME: | TREPROSTINIL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Prostacycline Vasodilator [EPC],Prostaglandins I [Chemical/Ingredient],Vasodilation [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | INHALANT |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2009-08-14 |
| END MARKETING DATE: | 0000-00-00 |
TYVASO HUMAN PRESCRIPTION DRUG Details:
| Item Description | TYVASO from United Therapeutics Corp. |
| LABELER NAME: | United Therapeutics Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1.74(mg/2.9mL) |
| START MARKETING DATE: | 2009-08-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 66302-206_48a56429-cb1f-4659-ac4b-c2bb1e5316c1 |
| PRODUCT NDC: | 66302-206 |
| APPLICATION NUMBER: | NDA022387 |
Other TREPROSTINIL Pharmaceutical Manufacturers / Labelers:
